Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome: Commentary on: DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Wallentin, L; Becker, RC; Cannon, CP; Held, C; Himmelmann, A; Husted, S; James, SK; Katus, HS; Mahaffey, KW; Pieper, KS; Storey, RF; Steg, PG; Harrington, RA

Published Date

  • January 1, 2014

Published In

Volume / Issue

  • 170 / 3

Start / End Page

  • e59 - e62

PubMed ID

  • 24299581

Electronic International Standard Serial Number (EISSN)

  • 1874-1754

Digital Object Identifier (DOI)

  • 10.1016/j.ijcard.2013.11.003


  • eng

Conference Location

  • Netherlands